Thomas O McDonald

5PUBLICATIONS
29CO-AUTHORS
Cancer geneticsPharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 08, 2026
A pan-cancer single-cell analysis of intratumoral copy number diversity and evolution.

|Nov 17, 2025
BESTDR Enables Bayesian Quantification of Mechanism-Specific Drug Responses.

Thomas O McDonald, Simone Bruno, James P Roney

|Jun 19, 2025
Response to: Correspondence on "Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab" by Gao et al.

Christopher Graser, Thomas O McDonald, Paul J Catalano

|May 09, 2025
Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab.

Christopher J Graser, Thomas O McDonald, Paul J Catalano

|Nov 03, 2023
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor-positive Breast Cancer.

Yu-Chen Cheng, Shayna Stein, Agostina Nardone

Pageof 1

Frequent Collaborators

5 joint publications

Franziska Michor

2 joint publications

Guru Sonpavde

2 joint publications

Christopher J Graser

2 joint publications

Paul J Catalano